Stimulation

Stimulation is a state of heightened physical and mental activation — increased energy, alertness, and drive arising acutely from psychoactive substances.

As a drug effect it is acute and dose-proportional, easing as the substance wears off, which sets it apart from baseline temperament or clinical conditions such as mania. It ranges from a mild lift in energy and focus to intense restlessness and agitation, with the latter carrying real discomfort at high doses.

Stimulation is one of the most commonly reported effects across psychoactive classes. It is most commonly induced at low to moderate doses under stimulants such as amphetamine, MDMA, and modafinil, and under psychedelics such as LSD, psilocybin mushrooms, and DMT. It also appears under dissociatives such as ketamine and dextromethorphan, and at lower intensity under nootropics such as aniracetam and coluracetam.

Stimulation is felt as a surge of wakefulness and physical drive: thoughts arrive quickly, attention sharpens, and a push toward activity — talking, moving, doing — becomes difficult to resist.

It commonly comes with a quickened heartbeat, raised body temperature, and a sense of physical readiness, as though the body is primed for exertion. Attending to the activated state tends to amplify it — noticing the energy intensifies the urge to act on it. At higher doses, particularly under stimulants, this can tip into agitation, jaw tension, and an uncomfortable inability to rest.

Stimulation arises through different pathways depending on the drug class:

• Stimulants — increase monoamine activity, principally dopamine and norepinephrine, raising arousal and motor drive directly.
• Psychedelics — act on 5-HT2A receptors, producing stimulation as a component of broader cortical activation alongside perceptual changes.
• Dissociatives — block NMDA receptors; at lower doses this can produce paradoxical stimulation rather than sedation.
• Nootropics — modulate cholinergic and glutamatergic signaling, producing a milder, alertness-enhancing effect.

How much each pathway contributes in a given case is not fully understood.

Who experiences it, and how strongly, varies widely. Higher doses reliably intensify both energy and restlessness. It is more pronounced in novel settings or during periods of low baseline fatigue — especially under stimulants and psychedelics — and in people with an energetic or anxious disposition or prior sensitivity to arousal.

Expectation shapes it: going in anticipating strong activation tends to amplify the effect. A history of regular stimulant use and adequate sleep before a session can reduce its intensity.